Document:

exv10w3w13

EXHIBIT 10.3.13

Senior Term C Note

	 	 	 
	Purchaser: American Capital Strategies, Ltd.
	 	Horseheads, New York
	Principal Amount: $4,000,000
	 	October 29, 2004

          For value received, the undersigned, IST Acquisitions, Inc., a Delaware corporation
(“Parent”), Imaging and Sensing Technology Corporation, a New York corporation (“Borrower”), I.S.
Technology de Puerto Rico, Inc., a Delaware corporation, IST Instruments, Inc., a New York
corporation, Imaging and Sensing Technology International Corp., a New York corporation, IST Conax
Nuclear, Inc., a New York Corporation, and Quadtek, Inc., a Washington corporation (the
“Subsidiaries,” and, together with Parent and Borrower, the “Loan Parties”), hereby jointly and
severally promise to pay to the order of the Purchaser set forth above (the “Purchaser”) the
principal amount set forth above or, if less, the aggregate unpaid principal amount of this Senior
Term C Note (the “Senior Term C Note”) set forth above, payable at such times, and in such amounts,
as are specified in the Amended and Restated Note and Equity Purchase Agreement, dated as of
October 29, 2004, among the Loan Parties, American Capital Financial Services, Inc., as Agent, and
the other parties thereto, as the same may be amended, restated, supplemented or otherwise modified
from time to time (the “Amended Purchase Agreement”).

          The Loan Parties jointly and severally promise to pay interest on the unpaid principal amount
of this Senior Term C Note from the date made until such principal amount is paid in full, at such
interest rates, and payable at such times, as are specified in the Amended Purchase Agreement.

          Both principal and interest are payable in the lawful money of the United States of America as
follows:

If by U.S. Mail to:

American Capital Financial Services, Inc., as Agent

ACS Funding Trust I, NW 7941

P.O. Box 1450

Minneapolis, MN 55485-7941

If by Overnight Service to:

NW 7941 c/o Regular ACS Funding Trust I

1350 Energy Lane, Suite 200

St. Paul, MN 55108

If by wire transfer to:

Wells Fargo Bank, N.A.

ABA xxxxxxxxx

Account Name: ACS Funding Trust I

Account #: xxxx-xxxxxx

          This Senior Term C Note is one of the Senior Term C Notes referred to in, and is entitled to
the benefits of, the Amended Purchase Agreement. Capitalized terms used herein and not defined
herein are used herein as defined in the Amended Purchase Agreement.

          The Amended Purchase Agreement, among other things, (i) provides for the purchase of the
Senior Term C Notes by the Purchaser in an aggregate amount not to exceed at any time outstanding

 

 

the Principal Amount set forth above, the indebtedness of the Loan Parties resulting from such
purchase being evidenced by this Senior Term C Note and (ii) contains provisions for acceleration
of the maturity of the unpaid principal amount of this Senior Term C Note upon the happening of
certain stated events and also for prepayments on account of the principal hereof prior to the
maturity hereof upon the terms and conditions therein specified.

          This Senior Term C Note is secured as provided in the Security Documents.

          Demand, diligence, presentment, protest and notice of non-payment and protest are hereby
waived by the Loan Parties.

          This Senior Term C Note shall be governed by, and construed and interpreted in accordance
with, the laws of the State of New York.

2 

 

          In witness whereof, the Loan Parties have caused this Senior Term C Note to be
executed and delivered by their respective duly authorized officer as of the day and year and at
the place set forth above.

	 	 	 	 	 
	 	LOAN PARTIES:

IST ACQUISITIONS, INC.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	IMAGING AND SENSING TECHNOLOGY CORPORATION

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	IST CONAX NUCLEAR, INC.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	I.S. TECHNOLOGY de PUERTO RICO, INC.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	IMAGING AND SENSING TECHNOLOGY

INTERNATIONAL CORP.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	IST INSTRUMENTS, INC.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	QUADTEK, INC.

 	 
	 	By:  	/s/ Donald Hartman
 	 
	 	 	Name:  	Donald Hartman 	 
	 	 	Title:  	Chief Executive Officerexv10w3w14

EXHIBIT
10.3.14

IST ACQUISITIONS, INC.

STOCKHOLDERS AGREEMENT

     THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is entered into as of May 24, 2004, by
and among IST ACQUISITIONS, INC., a Delaware (the “Corporation”), AMERICAN CAPITAL
STRATEGIES, LTD., a Delaware corporation (together with its transferees, “ACAS”) and each
of the persons who executes this Agreement as a stockholder of the Corporation.

WITNESSETH:

     WHEREAS, the Corporation is presently authorized to issue 125,000 shares of Class A Voting
Common Stock, par value $0.001 per share (“Class A Common Stock”), 125,000 shares of Class
B Non-Voting Common Stock, par value $0.001 per share (“Class B Common Stock” and, together
with the Class A Common Stock, the “Common Stock”), and 100,000 shares of Series A
Redeemable Paid-in-kind Preferred Stock, par value $0.001 per share (“Preferred Stock”);

     WHEREAS, ACAS has received shares of Common Stock, Preferred Stock and warrants to purchase
shares of Common Stock (“Warrants”) pursuant to the Note and Equity Purchase Agreement,
dated May 24, 2004, by and between the Corporation, Imaging and Sensing Technologies Corporation
(“IST”), certain subsidiaries of IST, American Capital Financial Services, Inc. and the
Purchasers party thereto (the “Purchase Agreement”); and

     WHEREAS, the Employee Stockholders (as hereafter defined) have received the Corporation
Securities (as hereinafter defined) listed on Schedule A hereto; and

     WHEREAS, ACAS and the Employee Stockholders party hereto (collectively, and together with any
stockholders who become a party hereto after the date hereof, the “Stockholders”) and the
Corporation desire to enter into this Agreement for the purposes, among others, of (i) assuring
continuity in the management and ownership of the Corporation and (ii) limiting the manner and
terms by which the Corporation Securities may be transferred.

     NOW THEREFORE, in consideration of the mutual covenants and agreements of the parties hereto,
and of the mutual benefits to be gained by the performance thereof, and for other good and valuable
consideration, the receipt whereof each to the other is hereby acknowledged, the parties for
themselves, their heirs, executors, administrators, successors and assigns, do hereby covenant and
agree as follows:

 

 

ARTICLE 1

Certain Defined Terms

     As used in this Agreement, the following additional terms, not defined elsewhere, have the
meanings herein specified:

     “ACAS” shall have the meaning ascribed thereto in the Recitals.

     “ACAS Sale Notice” shall have the meaning set forth in Section 3.05.

     “Affiliate” shall mean a Person that is controlled by, that controls or that is under
common control with a particular Person and shall specifically include any present or former
officer, director or employee of a particular Person.

     “Board of Directors” shall mean the Board of Directors of the Corporation.

     “Bona Fide Offer” shall mean a bona fide firmly committed offer that is not adverse to
the interests of the Corporation or its Stockholders, as reasonably determined by ACAS, from a
Person other than the Corporation, for the Transfer of Corporation Securities owned by a Selling
Stockholder. In determining whether an offer is a Bona Fide Offer, ACAS may take into account,
without limitation, the following:

     (i) whether the offeror is a competitor of or an investor In a competitor of the Corporation
or any of its Subsidiaries;

     (ii) the offeror’s financial resources and capability of completing the purchase and meeting
other capital requirements that might be sought of stockholders; and

     (iii) the purchase price and other material terms surrounding the purchase of the Corporation
Securities.

     “Bona Fide Offeror” shall mean any Person or other entity who has made a Bona Fide
Offer to a Selling Stockholder in accordance with Article 3.

     “Business Day” shall mean any day of the year on which national banking institutions
in York and Bethesda, Maryland are open to the public for conducting business and are not required
or authorized to close.

     “Cause” shall mean that an Employee Stockholder has:

     (i) committed or engaged in an act of fraud, embezzlement, sexual harassment, dishonesty or
theft in connection with his or her duties for the Corporation or any Subsidiary;

2

 

     (ii) materially breached or defaulted under his or her agreements or obligations under his or
her employment agreement or his or her confidentiality, non-competition and intellectual property
agreement or any similar agreements with the Corporation or any Subsidiary;

     (iii) been convicted of, or pleas nolo contendre with respect to, an act of criminal
misconduct;

     (iv) engaged in an act of incompetence, gross negligence or willful failure to perform his or
her duties or responsibilities; or

     (v) failed to follow in any material respect a direction or policy of the Board of Directors
of the Corporation or any Subsidiary.

Notwithstanding the foregoing, in the event that the Corporation or any Subsidiary provides notice
of termination for Cause in reliance upon the circumstances contained in (iv) or (v) above,
Employee Stockholder shall have the opportunity to cure such circumstances within two (2) Business
Days of receipt of such notice.

     “Commission” shall mean the Securities and Exchange Commission or any successor agency
of the federal government serving a similar function.

     “Common Stock” shall have the meaning ascribed to such term in the Recitals hereto.

     “Competitive Acts” shall mean any of the actions described in Exhibit A
hereto.

     “Corporation Securities” shall mean, collectively, Common Stock, Preferred Stock,
Warrants, including any securities issuable upon exercise of Warrants or other options and warrants
or other securities issued from time to time by the Corporation, whether pursuant to the Option
Plan or otherwise.

     “Debt Instrument” shall mean any loan agreement, credit agreement, promissory note,
note purchase agreement, capital lease, guarantee or other agreement or instrument of indebtedness
of the Corporation or the terms and conditions of any preferred stock or other securities issued by
the Corporation that are senior in priority to the Common Stock; but shall not include any trade
indebtedness or accounts payable incurred by the Corporation in the ordinary course of business or
any agreements regarding payment of the same; shall not include any indebtedness to Stockholders or
former Stockholders of the Corporation with respect to purchase options or redemption rights set
forth in this Agreement, in the Purchase Agreement or otherwise; and shall not include any

3

 

indebtedness to Stockholders or former Stockholders of the Corporation under any stock
appreciation rights plan or similar plan.

     “Disability” shall mean a physical or mental incapacity or disability which renders
the Employee Stockholder substantially unable to render services to the Corporation or any
Subsidiary (i) for one hundred twenty (120) days in any twelve (12) month period or (ii) for a
period of ninety (90) successive days, as determined by the Board of Directors in its sole
discretion.

     “Discounted Value” shall mean, with respect to any particular Corporation Securities,
fifty percent (50%) of the lower of the then Fair Market Value or Original Cost of such Corporation
Securities.

     “Employee Stockholders” shall mean the Employee Stockholders set forth in Schedule A
hereto, any employees of the Corporation who become a party to this Agreement, and their respective
successors and permitted assigns.

     “Estate” shall mean and include the executors or administrators of a deceased
Stockholder, and any and all Persons who may claim any interest in his property under such deceased
Stockholder’s will or by virtue of any laws of descent and distribution.

     “Exempt Transfer” shall have the meaning ascribed to such term in Section 3.01 hereto.

     “Fair Market Value” shall mean the fair market value of a particular type of
Corporation Securities, as determined in accordance with this definition. The Fair Market Value of
a share of Common Stock or Preferred Stock will be equal to its value determined in connection with
a Sale Transaction, and if not available, its Market Price, and if not available, its value as
determined in good faith by the Board of Directors. The Fair Market Value of the Warrants shall be
equal to the aggregate Fair Market Value of the shares of Common Stock or Preferred Stock for which
such Warrants may then be exercised minus the exercise price to be paid in connection with such
exercise. In the event of disputes as to the Fair Market Value of a particular type of Corporation
Securities, the Board of Directors shall determine such Fair Market Value in its good faith
judgment.

     “Financing Conveyance” shall mean a pledge or collateral assignment of a security to a
third party lender to or financing source for (including any agents therefor) ACAS or any of its
Affiliates, and any subsequent foreclosure, deed in lieu of foreclosure or similar event or
transaction whereby such security is further sold, assigned or conveyed and any subsequent sale,
assignment or conveyance of such security by or to any Person thereafter.

4

 

     “Fully Diluted Basis” shall mean the determination of the percentage ownership of a
particular type of Corporation Securities based on the number of all outstanding securities of such
type as if all securities eligible for conversion into or that are exercisable or exchangeable for
such class of Corporation Securities had been converted or exercised (including Warrants, which
shall be considered exercised for their maximum number of shares of the type of Corporation
Securities for which they are exercisable, but excluding any shares of Common Stock that may be
issued upon the exercise of options under the Option Plan or any similar plan if such options have
not vested).

     “Incentive Stock” shall mean any shares of Common Stock acquired by Employee
Stockholders pursuant to the Option Plan or under or any other present or future incentive plan or
program for employees or consultants to the Corporation or any of its Affiliates, whether through
the exercise of stock options or warrants or as a result of the grant of restricted stock,
including any shares of Common Stock issued as a result of such securities, whether by way of stock
split, dividend or otherwise. Corporation Securities shall continue to be “Incentive Stock” while
owned by an Employee Stockholder’s successors and permitted assigns. Shares of restricted stock
shall become “Incentive Stock” when owned outright by an Employee Stockholder (i.e., when all
vesting and other similar restrictions have lapsed). For purposes hereof, Incentive Stock shall
also be deemed to include Corporation Securities purchased by an Employee Stockholder from the
Company in connection with the closing of the acquisition of IST by the Company.

     “IST” shall have the meaning ascribed thereto in the recitals.

     “Market Price” of any security shall mean the average of the closing prices of such
security’s sales on all securities exchanges on which such security may at the time be listed or,
if there have been no sales on any such exchange on any day, the average of the highest bid and
lowest asked prices on all such exchanges at the end of each day or, if on any day such security is
not so listed, the average of the representative bid and asked prices quoted on the Nasdaq Stock
Market System as of 4:00 P.M., New York time or, if on any day such security is not quoted on the
Nasdaq Stock Market System, the average of the highest bid and lowest asked prices on such day in
the domestic over-the-counter market as reported by the National Quotation Bureau, Incorporated, or
any similar successor organization, in each such case averaged over a period of thirty (30) days
consisting of the day immediately preceding the day as of which “Market Price” is being determined
and the twenty-nine (29) consecutive days prior to such day.

     “Maximum Redemption Amount” shall have the meaning ascribed thereto in Section 5.04.

5

 

     “Non-Compete Period” shall mean with respect to any Employee Stockholder, the
noncompetition period provided in any agreement between the Corporation or any Subsidiary and such
Employee Stockholder or, if there is no such agreement, three 3 years.

     “Offered Securities” shall mean the shares of Corporation Securities that a Selling
Stockholder proposes to sell pursuant to a Sale Notice in accordance with Article 3.

     “Option Plan” shall mean the Corporation’s 2004 Stock Plan, as the same may be adopted
and amended from time to time.

     “Original Cost” shall mean, initially, $100.00 per share, in the case of Common Stock,
$1,000.00 per share, in the case of Preferred Stock, and the applicable option or warrant exercise
price, in the case of Incentive Stock which are options or warrants. Original Cost of any
Corporation Securities issued or sold after the date hereof shall be the original purchase price
thereof or, in the case of options or warrants, the exercise price.

     “Other Stockholders” shall mean, (a) in connection with any Transfer governed by
Section 3.02, 3.03 and 3.04, the Stockholders who are parties hereto other than ACAS and the
Selling Stockholder in respect of such Transfer and, (b) in all other cases, the Stockholders
(including Employee Stockholders) who are parties hereto other than ACAS.

     “Partial Termination” shall have the meaning set forth in Section 3.01.

     “Permitted Transferee” shall mean (i) a Stockholder’s Estate and heirs, (ii) such
other persons who may be so designated by the Board of Directors, (iii) any estate planning trust
of a Stockholder provided that the grantor Stockholder is trustee of such trust, or (iv) such other
personal estate or tax planning vehicle or device of which the grantor Stockholder is a controlling
Person with respect to the voting and the disposition of the Corporation Securities held thereby.

     “Person” shall mean any individual, partnership, limited partnership, corporation,
limited liability corporation, association, joint stock corporation, trust, joint venture,
unincorporated organization or governmental entity or department, agency or political subdivision
thereof.

     “Pro Rata Share” shall have the meaning set forth in Section 3.03.

     “Promissory Note” shall mean a promissory note issued by the Corporation in favor of a
Stockholder pursuant to Articles 5 or 6 (i) payable quarterly in level principal payments over a
period not in excess of five (5) years; (ii) that bears interest at a floating rate of two hundred
(200) basis points over the

6

 

“prime rate” in effect from time to time as reported under current practice under the heading
“Money Rates” in The Wall Street Journal and if a range of rates is listed, the lowest such rate
(and if The Wall Street Journal should discontinue such practice, such other indication of the
“prime rate” as the Board of Directors shall reasonably determine); (iii) secured at least by the
Corporation Securities that were the subject of the purchase for which the Promissory Note is
given; and (iv) that is subordinated to any and all indebtedness for borrowed money of the
Corporation (whether to ACAS, any Affiliate of ACAS or any other Person).

     “Public Sale” shall mean any sale pursuant to an underwritten registered public
offering under the Securities Act or any sale pursuant to Rule 144 promulgated under the Securities
Act.

     “Purchase Agreement” shall have the meaning assigned to such term in the recitals.

     “Purchaser” shall mean any Stockholder who has elected to purchase Offered Securities
in accordance with Section 3.03.

     “Put Notice” shall mean a written notice given to the Corporation pursuant to Section
5.01 by a holder of Incentive Stock of his or her election to have the Corporation redeem all or
less than all of such holders’ Incentive Stock. The Put Notice shall set forth the number and type
of shares to be redeemed.

     “Registrable Securities” shall mean all shares of Common Stock owned by the Other
Stockholders, including any Common Stock received as a result of the exercise of the Warrants or as
a result of splits, stock dividends or similar events. Any Registrable Securities will cease to be
such when (i) a registration statement covering such Registrable Securities has been declared
effective by the Commission and such Registrable Securities have been disposed of pursuant to such
effective registration statement, (ii) such Registrable Securities are distributed to the public
pursuant to Rule 144 (or any similar provision then in effect) under the Securities Act or (iii)
such Registrable Securities may be resold to the public without restriction under the Securities
Act in accordance with Rule 144(k).

     “Registration Expenses” shall have the meaning ascribed to such term in Section 8.05
hereof.

     “Sale Notice” shall have the meaning set forth in Section 3.02.

     “Sale Transaction” shall mean a transaction or a series of related transactions
involving (a) the sale of eighty percent (80%) or more of the assets (based on their fair market
value) of the Corporation; (b) any consolidation, merger or recapitalization of the Corporation (i)
in which the Corporation is not

7

 

the continuing or surviving corporation or (ii) pursuant to which the Corporation’s voting
stock would be converted into cash, securities and/or other property, in each case other than any
such transaction in which holders of the Corporation’s voting stock immediately before the
transaction, in the aggregate, have (or upon conversion, exercise or similar action would have)
more than fifty percent (50%) of the voting power of all issued and outstanding securities of the
surviving corporation after the transaction; (c) the liquidation or dissolution of the Corporation;
or (d) any sale to a Person not Affiliated with a then current stockholder of voting stock
representing more than fifty percent (50%) of the votes eligible to be cast by stockholders of the
Corporation in the election of members of the Board of Directors.

     “Securities Act” shall mean the Securities Act of 1933, as amended.

     “Selling Stockholder” shall mean a Stockholder, other than ACAS (or any successor
thereto or assignee thereof) who has delivered a Sale Notice.

     “Stockholders” shall have the meaning ascribed to such term in the Recitals hereto and
any future stockholder of the Corporation who agrees to bind itself as a Stockholder hereto in
accordance with this Agreement.

     “Stock Purchase Agreement” shall mean the Stock Purchase Agreement, dated May 24,
2004, among the Corporation and the security holders of Imaging and Sensing Technology Corporation
who are signatories thereto.

     “Subsidiary” shall mean any corporation or entity (other than the Corporation) in an
unbroken chain of corporations or entities beginning with the Corporation, if each of the
corporations other than the last corporation in the unbroken chain owns stock possessing fifty
percent (50%) or more of the total combined voting power of all classes of stock or ownership
interests in one of the other corporations or entities in such chain. A corporation or entity that
attains the status of a Subsidiary on a date after the execution of this Agreement shall be
considered a Subsidiary commencing as of such date.

     “Transfer” shall mean, with respect to any Corporation Securities, any sale,
assignment, transfer, alienation, conveyance, gift, bequest by will or under intestacy laws,
pledge, lien, encumbrance or other disposition, with or without consideration and whether
voluntarily or involuntarily by operation of law, of all or part of such Corporation Securities, or
of any beneficial interest therein, now or hereafter owned by a Stockholder. Transfer shall not
include the transfer, direct or indirect, of any interest in any Corporation Securities by ACAS or
any successor or assignee of ACAS. “Transferred” shall have the correlative meaning.

     “Warrants” shall have the meaning ascribed to such term in the Recitals hereto.

8

 

ARTICLE 2

Stockholders’ Covenants, Representations and Warranties

     Each of the Stockholders represents and warrants severally, to each of the other Stockholders
and to the Corporation, that this Agreement constitutes the legal, valid and binding obligation of
such Stockholder, enforceable against such Stockholder in accordance with its terms, and the
execution, delivery and performance of this Agreement by such Stockholder does not and will not
conflict with, violate or cause a breach of any agreement, contract or instrument to which such
Stockholder is a party or any judgment, order to decree to which such Stockholder is subject.

ARTICLE 3

General Restrictions on Disposition of Shares

     Section 3.01. Transfer of Securities. No Other Stockholder shall undertake a Transfer of
Corporation Securities except pursuant to (i) a Public Sale, (ii) a Transfer to a Permitted
Transferee that agrees to be bound by the terms hereof and that complies with the terms of this
Agreement (each of (i) and (ii), an “Exempt Transfer”), (iii) in connection with a Bona
Fide Offer in accordance with Sections 3.02, 3.03 and 3.04, or (iv) Articles 5 or 6 of this
Agreement. In addition, no Other Stockholder may undertake a Transfer of any Corporation Securities
(except to ACAS or the Other Stockholders pursuant to Section 3.03 or pursuant to an effective
registration statement under the Securities Act) without first delivering to the Corporation an
opinion of counsel (reasonably acceptable in form and substance to the Corporation) that no
registration under the Securities Act is required in connection with such Transfer. The
restrictions on the Transfer of Corporation Securities set forth in this Article 3 shall continue
with respect to each share of Corporation Securities governed hereunder until the date on which the
Corporation completes an initial public offering of the Corporation Securities under the Securities
Act or completes a Sale Transaction in which the surviving corporation or its parent has a class of
securities registered under the Securities Exchange Act of 1934, as amended (each, a “Partial
Termination”).

     Section 3.02. Notice of Proposed Sale of Corporation Securities. In advance of any proposed
Transfer other than an Exempt Transfer, an Other Stockholder (the “Selling Stockholder”)
will give written notice to the Corporation, ACAS and the Other Stockholders that the Selling
Stockholder believes it has a Bona Fide Offer that it desires to accept. Such notice will disclose
the number and type of shares of Corporation Securities to be sold, the identity of the Bona Fide
Offeror and the terms and conditions of the proposed Transfer and shall contain such other
information as would be required (or as ACAS may subsequently request) to enable ACAS to determine
whether such

9

 

proposed offer is a Bona Fide Offer. The Selling Stockholder will not consummate any Transfer
other than an Exempt Transfer until (a) ACAS has notified the Selling Stockholder, the Corporation
and the Other Stockholders that it has determined that the proposed Transfer is pursuant to a Bona
Fide Offer (the “Sale Notice”) (b) thirty-five (35) days after ACAS delivers such notice of
favorable determination, unless the parties to the Transfer have been finally determined pursuant
to Sections 3.03 and 3.04 prior to the expiration of such thirty-five (35) day period and (c) the
Bona Fide Offeror to such Transfer has indicated in writing that it will execute and deliver a
counterpart to this Agreement binding itself as a Stockholder to the terms hereof upon the
consummation of such proposed Transfer.

     Section 3.03. Right of First Refusal. If a Selling Stockholder delivers a Sale Notice
pursuant to Section 3.02, such notice shall be deemed to constitute an offer by the Selling
Stockholder to Transfer (in accordance with and subject to the provisions of this Section 3.03)
all, but not less than all, of the Corporation Securities identified in the Sale Notice (the
"Offered Securities”), at the price and upon the other terms and conditions described in
the Sale Notice to ACAS and the Other Stockholders on at least a pro rata basis in accordance with
the number of shares of Common Stock or Preferred Stock, as the case may be, owned by each of them
in relation to the number of shares of Common Stock or Preferred Stock, as the case may be, owned
by the Stockholders, other than the Selling Stockholder, on a Fully Diluted Basis (as to each of
ACAS and the Other Stockholders, its “Pro Rata Share”).

     (a) Upon receipt of a Sale Notice, ACAS and each Other Stockholder may exercise its purchase
rights under this Section 3.03 by delivering written notice to the Selling Stockholder and the
Corporation stating the number of Offered Securities ACAS or such Other Stockholder desires to
purchase within twenty (20) days after receipt of the Sale Notice. If either ACAS or any Other
Stockholder fails to deliver a notice setting forth its election to purchase all or any portion of
the Offered Securities within such twenty (20) day period, each such Stockholder shall be deemed
irrevocably to have elected not to purchase the Offered Securities. If ACAS and the Other
Stockholders elect to purchase an aggregate number of Offered Securities greater than the total
number of Offered Securities, each of ACAS and such Other Stockholders shall be entitled to
purchase (i) its Pro Rata Share of the type of Offered Securities (i.e. Common Stock and
its equivalents or Preferred Stock) plus, (ii) as to those Other Stockholders and, if applicable,
ACAS, that have elected to purchase a number of Offered Securities greater than their respective
Pro Rata Shares (determined as aforesaid), the amount so elected for purchase allocated among such
Stockholders based on their respective Pro Rata Shares (determined as aforesaid) up to the number
of Offered Securities elected to be purchased by each such Stockholder.

10

 

     (b) If ACAS and the Other Stockholders (as applicable, the “Purchaser”) have together
elected to purchase all or any portion of the Offered Securities, then the Selling Stockholder
shall sell such Offered Securities to the Purchaser, and the Purchaser shall acquire such Offered
Securities from the Selling Stockholder, at the price and on the other terms described in the Sale
Notice. The consummation of the Transfer shall take place at 10:00 a.m. local time at the offices
of the COIporation, on the earlier of (i) the date specified for the proposed Transfer in the
notice from the applicable Purchaser accepting the offer set forth in the Sale Notice, or (ii) the
closing date specified by the Selling Stockholder in the Sale Notice, at which time the Purchaser
shall deliver the appropriate consideration, and the Selling Stockholder shall deliver certificates
representing the Offered Securities to be sold, free and clear of any and all liens, claims and
encumbrances whatsoever (except those imposed by this Agreement and federal and any applicable
state securities laws generally), together with such other instruments and documents of transfer as
the Purchaser shall reasonably request.

     (c) If ACAS and the Other Stockholders do not purchase all of the Offered Securities, then the
Selling Stockholder may Transfer the Offered Securities not purchased pursuant to this Section 3.03
in accordance with the Bona Fide Offer to the Bona Fide Offeror within fifteen (15) Business Days
of the expiration of the thirty-five (35) day period specified in Section 3.02 above, provided,
however, that such Transfer may be made at any earlier date selected by the Selling Stockholder,
after the Selling Stockholder shall have received written notice from ACAS and all of the Other
Stockholders that ACAS and such Other Stockholders have elected not to purchase all of the Offered
Securities. Upon a Transfer by the Selling Stockholder of the Offered Securities to the Bona Fide
Offeror, the Bona Fide Offeror shall execute and deliver a counterpart to this Agreement binding
itself as a Stockholder to the terms hereof.

     (d) Promptly after any Transfer of Offered Securities pursuant to this Section 3.03, the
Selling Stockholder shall notify the Corporation of the consummation thereof and shall promptly
furnish such evidence of the completion (including date of completion) of such Transfer and such
other information regarding such Transfer as the Corporation may reasonably request.

     Section 3.04. Co-Sale Right of ACAS. ACAS may elect to participate in the contemplated
Transfer by a Selling Stockholder as may be specified in a Sale Notice pursuant to Section 3.02
above by delivering written notice to the Selling Stockholder and the Corporation within twenty
(20) days after ACAS has been given the Sale Notice. If ACAS has elected to participate in such
Transfer, ACAS will be entitled to sell in the contemplated Transfer, at the same price and on the
same terms as the Selling Stockholder who is Transferring Corporation Securities, a number and type
of shares of Corporation Securities equal to the product of (i) the quotient determined by dividing
the percentage of the Corporation Securities

11

 

of such type held by ACAS (on a Fully Diluted Basis)
by the aggregate percentage of the Corporation Securities of such type owned by the Selling
Stockholder and ACAS (on a Fully Diluted Basis) and (ii) the number of shares of Common Stock to be
Transferred in the contemplated transaction.

For example, if the Sale Notice contemplated a Transfer of 100 shares of Common Stock, and
if the Selling Stockholder was at such time the owner of 30% of the Common Stock (on a
Fully Diluted Basis) and if ACAS elected to participate and ACAS owned 20% of the Common
Stock (on a Fully Diluted Basis), the Selling Stockholder would be entitled to sell 60
shares (30% ÷ 50% x 100 shares) and ACAS would be entitled to sell 40 shares (20% ÷ 50% x
100 shares).

The Selling Stockholder will use reasonable commercial efforts to obtain the agreement of the
prospective transferee(s) to the participation of ACAS in the contemplated Transfer and will not
Transfer any Corporation Securities to the prospective transferee(s) if such transferee(s) refuses
to allow the participation of ACAS. In connection with any such sale of Common Stock, ACAS may
elect to
exercise the Warrants and participate in such sale as a holder of Common Stock or, in lieu of such
exercise, to receive in exchange for such Warrants, the excess of the consideration per share of
Common Stock receivable in such sale over the exercise price per share under the Warrants.

     Section 3.05. Tag-Along Rights. In the event that ACAS elects to sell or have redeemed more
than fifty percent (50%) of its holdings of any Corporation Securities other than Preferred Stock
(determined on a Fully Diluted Basis) in one transaction or a series of related transactions, it
shall provide written notice (an “ACAS Sale Notice”) to all Other Stockholders that such
Other Stockholders have the right to participate in the contemplated sale or redemption by
delivering written notice to ACAS and the Corporation within twenty (20) days after the date of
delivery of the ACAS Sale Notice. If an Other Stockholder elects to participate in such sale or
redemption, such Stockholder will be entitled to sell in the contemplated sale or redemption, at
the same price and on the same terms as ACAS is selling Corporation Securities (other than
Preferred Stock), a number of Corporation Securities equal to the product of (i) the quotient
determined by dividing the percentage of the Common Stock (on a Fully Diluted Basis) held by such
Other Stockholder by the aggregate percentage of the Common Stock (on a Fully Diluted Basis) owned
by ACAS and such Other Stockholder and (ii) the number of shares of Corporation Securities to be
sold in the contemplated sale.

For example, if the ACAS Sale Notice contemplated a sale of 100 shares of Common Stock,
and if ACAS was at such time the owner of 30% of the Common Stock (on a Fully Diluted
Basis) and if such Other Stockholder who elected to participate owned 20% of the Common
Stock (on a Fully

12

 

Diluted Basis), then ACAS would be entitled to sell 60 shares (30% ÷ 50%
x 100 shares) and such Other Stockholder would be entitled to sell 40 shares (20% ÷ 50% x
100 shares).

ACAS will use reasonable commercial efforts to obtain the agreement of the prospective
transferee(s) to the participation of each other participating Other Stockholder in the
contemplated sale and will not Transfer any Corporation Securities to the prospective transferee(s)
if such transferee(s) refuses to allow the participation of each Other Stockholder electing to
participate in such transaction. In the event that any such sale provides for a sale of Corporation
Securities in conjunction with a sale of notes issued under the Purchase Agreement, or in the event
of the sale of multiple types of Corporation Securities (including Preferred Stock), the value to
be paid thereunder with regard to any particular class of securities will be assigned in the
following manner:

     (i) all outstanding notes issued under the Purchase Agreement will be valued at their
full outstanding principal amount plus all accrued and unpaid interest, prepayment
premiums and other fees and costs;

     (ii) all shares of Preferred Stock will be valued at their liquidation value plus,
without duplication, accrued and unpaid dividends;

     (iii) the remaining value will be allocated next to any Warrants included in such
sale, pro rata at their respective Fair Market Value; and

     (iv) any remaining value will then be allocated pro rata among shares of Common Stock
(on a Fully Diluted Basis, excluding any Warrants and treating the Class A Common Stock
and Class B Common Stock identically).

The rights granted under this Section 3.05 shall not apply in the case of any Transfer by ACAS to
an Affiliate of ACAS, or in connection with any Financing Conveyance, or the Transfer by ACAS, in
one transaction or a series of related transactions, of fifty percent (50%) or less of its
ownership in a particular type of Corporation Securities.

     If ACAS elects to sell the Warrants, the tag-along rights described in this Section 3.05 will
apply as though ACAS had elected to sell the Common Stock underlying such Warrants.

     Section 3.06. Drag-Along Rights. For so long as ACAS shall continue to own Corporation
Securities, ACAS shall have the right to require the Other Stockholders (i) to agree to and to sell
all of their respective Corporation Securities and any rights to acquire Corporation Securities
that they may own in each case on the same terms and conditions as ACAS proposes to sell all of its

13

 

Corporation Securities as reflected in a written notice provided to such Other Stockholders by ACAS
and (ii) as stockholders of the Corporation, to vote for a Sale Transaction proposed or endorsed by
ACAS in writing and approved by the Board of Directors. The obligations of the Other Stockholders
with respect to such sale of Corporation Securities or Sale Transaction are subject to the
conditions that, (i) upon the consummation of such sale or Sale Transaction, all of the holders of
each class of Corporation Securities will receive (subject to the sentence below) the same form and
amount of consideration per share in respect of such class of Corporation Securities and (ii) no
holder of Corporation Securities shall be required to incur indemnification obligations in
connection with such sale or Sale Transaction other than (x) pro rata obligations with respect to
representations, warranties and agreements of or regarding the Corporation (which in no event shall
exceed the sales proceeds received by such holder) or (y) obligations in connection with
representations, warranties and indemnification in respect of title of such Stockholder to its
Corporation Securities and other matters related to the legality of such Transfer by such
Stockholder. In connection with any such sale or Sale Transaction, each holder of vested options or
Warrants may elect to exercise such options or Warrants and participate in such sale or Sale
Transaction as a holder of Common Stock.

     Section 3.07. No Transfer in Contravention of this Agreement. Any attempted Transfer of
shares of Corporation Securities other than in accordance with this Agreement shall be null and
void and the Corporation shall refuse to recognize any such Transfer and shall not reflect on its
records any change in record ownership of shares of Corporation Securities pursuant to any such
Transfer.

ARTICLE 4

Legends on Certificates

     Section 4.01. During the term of this Agreement, each certificate or instrument representing
Corporation Securities subject to this Agreement shall bear the following legends on its face, or
upon the reverse side thereof, appropriately completed, which legends shall likewise be endorsed
upon all stock certificates representing shares of the Corporation’s capital stock that shall
hereafter be issued and which are subject to this Agreement:

“THE SECURITIES REPRESENTED BY THIS [CERTIFICATE] [WARRANT AND ANY SECURITIES ACQUIRED
UPON EXERCISE OF THIS WARRANT] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED OR ANY STATE SECURITIES LAWS AND NEITHER [THESE SECURITIES] [THIS WARRANT, SUCH
SECURITIES] NOR ANY INTEREST THEREIN

14

 

MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH
ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS.”

“THE SECURITIES REPRESENTED BY THIS [CERTIFICATE] [WARRANT] ARE SUBJECT TO THE CONDITIONS
ON TRANSFER SPECIFIED IN THE STOCKHOLDERS AGREEMENT DATED AS OF MAY 24, 2004, BY AND AMONG
THE CORPORATION AND THE STOCKHOLDERS OF THE CORPORATION. UPON WRITTEN REQUEST, A COPY OF
SUCH CONDITIONS WILL BE FURNISHED BY THE CORPORATION TO THE HOLDER HEREOF WITHOUT CHARGE.”

ARTICLE 5

Certain Put Rights Of Employee Stockholders

     Section 5.01. Put Rights. Subject to the limitations provided herein, including the
Corporation’s prior rights pursuant to Article 6, any Employee Stockholder may elect to have the
Corporation redeem all or less than all of such
holder’s Incentive Stock by tendering a Put Notice within ninety (90) days after the Employee
Stockholder’s death (in which case the Put Notice may be delivered by the Employee Stockholder’s
Estate) or Disability. The Corporation shall honor the Put Notice pursuant to this Section 5.01
within thirty (30) days of delivery by payment in cash of the Fair Market Value of the Incentive
Stock, unless performance by the Corporation is suspended by Section 5.03 or limited by Section
5.04 herein. If performance by payment in cash does become so suspended, then the Corporation
shall, unless prohibited by Section 5.03, deliver a Promissory Note for the suspended amount and
shall make payment thereunder to the extent consistent with Sections 5.03 and 5.04 until payment is
made in full, and shall accelerate payment thereunder to the extent permitted under Sections 5.03
and 5.04. For purposes of this Article 5, Fair Market Value of the Incentive Stock shall be
determined as of the date an Employee Stockholder or his/her Estate delivers a Put Notice to the
Corporation.

     Section 5.02. Retained Shares; Successor to Employee Stockholder. Any of the Incentive
Stock not purchased pursuant to Article 5 or Article 6 shall remain subject to Article 3 hereof.

     Section 5.03. Put Limitations. The rights of redemption available to the holders of
Incentive Stock pursuant to this Article 5 shall at all times be subject to limitations under the
Delaware General Corporation Law and any outstanding

15

 

Debt Instrument of the Corporation (without
regard to whether the holder of or lender under such Debt Instrument is a Stockholder or an
Affiliate thereof). Nothing herein shall require the Corporation to honor a Put Notice if such
would result in a violation of law or any such Debt Instrument, as determined in the good faith
judgment of the Board of Directors; provided, that, the Board of Directors shall use its
commercially reasonable efforts to obtain the approval of the holder(s) of any such Debt Instrument
to allow the Corporation to honor the Put Notice. At such time as redemption is permitted (a) under
the Debt Instruments described in this Section 5.03, and (b) without violation of law, the
Corporation shall make payment of any suspended payment obligation in Section 5.01 (whether in cash
or by issuance of Promissory Notes, as required by Section 5.01).

     Section 5.04. Maximum Redemption Amount. The Corporation shall be obligated to redeem in
cash no more than $250,000 (the “Maximum Amount”) of Incentive Stock annually, whether
pursuant to this Article 5 or pursuant to Article 6; provided, that, only the applicable annual
principal payment obligations under any Promissory Note issued or proposed to be issued for any
amount of the purchase price of Incentive Stock shall be included in calculating the Maximum
Redemption Amount.

     Section 5.05. Status of Redeemed Shares. Incentive Stock redeemed pursuant to this Article
5 shall no longer be deemed to be outstanding (except when such Incentive Stock is pledged as
security for a Promissory Note), and all rights of the holders thereof as stockholders of the
Corporation with respect to
those shares redeemed (except the right to receive the redemption price from the Corporation)
shall cease. Upon surrender of the certificates for Incentive Stock so redeemed, the Corporation
shall pay to the holder thereof the applicable redemption price as aforesaid. All redemption rights
applicable to Incentive Stock shall cease upon the redemption of such stock. Such Incentive Stock
shall, if reissued by the Corporation, be without a legend designating it as Incentive Stock.

     Section 5.06. Put Right of Employee Stockholder. Notwithstanding anything contained in this
Article 5, to the extent that an Employee Stockholder exercises his or her put rights in accordance
with the terms of hereof and his or her Corporation Securities are paid for with a Promissory Note,
the then outstanding balance of any such Promissory Note shall be forfeited by the Employee
Stockholder if the Employee Stockholder engages in a Competitive Act during the Non-Compete Period.

     Section 5.07. Lapse of Rights. An Employee Stockholder’s rights pursuant to this Article 5
shall lapse with respect to any Incentive Stock Transferred in connection with or after a Partial
Termination.

16

 

ARTICLE 6

Certain Call Rights of the Corporation from Employee Stockholders

     Section 6.01. Call Rights Generally. Each Employee Stockholder agrees that, in the event
that his or her employment with the Corporation shall terminate for any reason, any or all
Corporation Securities owned by him or her, his or her Estate or any of his or her Permitted
Transferees, whether now owned or subsequently acquired, may be purchased by the Corporation, (a)
in the case of any Employee Stockholder who (i) is terminated for Cause or (ii) voluntarily resigns
before the date that is three (3) years from the date hereof without Good Reason, for an aggregate
purchase price equal to the Discounted Value or (b) in the case of an Employee Stockholder whose
employment is terminated for any reason other than that set forth in (a) above for an aggregate
purchase price equal to the then Fair Market Value. To exercise its option set forth in Section
6.01, the Corporation shall deliver a written notice to the applicable Employee Stockholder setting
forth the number of Corporation Securities to be purchased and the applicable purchase price
thereof, and the date on which such purchase is to be consummated, which date shall be not less
than fifteen (15) days or more than thirty (30) days after the date of such notice. Such right may
be exercised by the Corporation with respect to an Employee Stockholder at any time prior to 180
days after the termination of such Employee Stockholder’s employment.

     Section 6.02. Call as a Result of a Competitive Act. Each Employee Stockholder agrees that,
in the event that (a) the Corporation does not elect to exercise its right to purchase the
Corporation Securities owned by him or her, his or her Estate or any of his or her Permitted
Transferees upon termination of his or
her employment pursuant to Section 6.01 and (b) such Employee Stockholder engages in a
Competitive Act at any time prior to the expiration of the applicable Non-Compete Period, any or
all of such Employee’s Corporation Securities, whether now owned or subsequently acquired, may be
purchased by the Corporation for an aggregate purchase price equal to the Discounted Value. To
exercise its option set forth in this Section 6.02, the Corporation shall deliver a written notice
to the applicable Employee Stockholder setting forth the amount of Corporation Securities to be
purchased, that the purchase is pursuant to Section 6.02, and the date on which such purchase is to
be consummated. Such rights may be exercised by the Corporation at any time prior to 180 days after
the expiration of the Non-Compete Period of such Employee Stockholder.

     Section 6.03. Call Limitation. The purchase of Corporation Securities by the Corporation
referred to in Section 6.01 and Section 6.02 shall be suspended at any time when purchase by the
Corporation is prohibited pursuant to (a) any applicable law; and (b) any Debt Instrument (without
regard to whether the holder of or lender under such Debt Instrument is a Stockholder or an
Affiliate thereof). Such purchase will be reinstated at such time as it may occur in accordance
with

17

 

(a) and (b) hereof. Notwithstanding anything else herein to the contrary, the Corporation may
assign its rights under this Section Article 6 to ACAS, in whole or in part, and with respect to
any one or more Employee Stockholders. For purposes of calculating the length of time in which the
Corporation may exercise its call right under this Article 6, if the purchase of Corporation
Securities is suspended pursuant to this Section 6.03, the Non-Compete Period shall be extended for
a period of time equal to the length of such suspension.

     Section 6.04. Payment. (a) Upon consummation of a sale made in accordance with Section 6.01
or 6.02 hereof, the Corporation shall deliver payment to the Stockholder in cash, unless
performance by the Corporation is suspended under Section 6.03. If performance by payment in cash
does become so suspended under Section 6.03, then the Corporation shall deliver, unless prohibited
by Section 6.03, a Promissory Note for the suspended amount and shall make payment thereunder to
the extent consistent with Section 6.03 until payment is made in full, and shall accelerate payment
to the extent permitted under Section 6.03. At such time as redemption is permitted (i) under the
Debt Instruments described in Section 6.03 and (ii) without violation of law, the Corporation shall
make payment of any suspended payment obligation in Section 6.01 or 6.02 (whether in cash or by
issuance of Promissory Notes as required hereby).

     (b) When payment is made in full in cash or by the delivery of a Promissory Note upon any sale
to the Corporation hereunder, the Stockholder shall deliver the certificate evidencing the
Corporation Securities being sold, duly endorsed for transfer, free and clear of any lien or
encumbrance, with all required federal and state documentary stamps and transfer taxes prepaid or
provided for. Upon full payment therefor, any Corporation Securities purchased by the
Corporation pursuant to this Article 6 shall be retired and shall have the status of
authorized but unissued capital stock.

     Section 6.05. Insurance. The Corporation may (but need not) apply for, obtain and maintain,
at its sole cost and expense, a life insurance policy on the life of any individual Stockholder,
and a policy of disability insurance as to any Employee Stockholder, which policy or policies shall
name the Corporation or any applicable lender to the Corporation as beneficiary and shall be for
such amounts as the Board of Directors may deem appropriate. Each individual Stockholder agrees to
submit himself or herself for physical examinations, execute and complete all necessary
questionnaires and consents, and cooperate with the Corporation to obtain the insurance described
herein, including any insurance obtained for the benefit of any lender to the Corporation.

     Section 6.06. Fair Market Value Determinations. For purposes of this Article 6, Fair Market
Value of an Employee Stockholder’s Corporation Securities shall be determined as of the date the
Corporation delivers notice to an

18

 

Employee Stockholder that it intends to exercise its rights under
this Article 6 with respect to such Employee Stockholder’s Corporation Securities.

     Section 6.07. Lapse of Rights. An Employee Stockholder’s Corporation Securities Transferred
in connection with or after a Partial Termination in a bona fide arm’s length transaction shall
thereupon cease to be subject to this Article 6.

ARTICLE 7

Rights Of First Offer

     Section 7.01. Sale of Securities. If the Corporation, after the date of this Agreement,
authorizes the issuance and sale of any shares of capital stock or any securities containing
options or rights to acquire any shares of capital stock (other than (a) shares or other securities
issued in connection with an underwritten public offering, (b) shares or other securities issued in
exchange for the securities or assets of another person as a party to an acquisition of a business
as a going concern, (c) shares or other securities issued or sold to parties that are (i) strategic
partners in connection with a commercial relationship with the Corporation or (ii) providing the
Corporation with equipment leases, real property leases, loans, credit lines, guarantees of
indebtedness, cash price reductions or similar transactions under arrangements approved by the
Board of Directors, (d) shares or other securities issued (i) upon the conversion of securities
outstanding on the date hereof or (ii) upon the conversion of convertible securities, the exchange
of exchangeable securities or the exercise of any options, warrants or other rights if either the
issuance of such convertible or exchangeable securities or such options, warrants or rights was
subject to the rights of first offer granted pursuant to this Section 7.01 or was exempted from the
application of this Section 7.01, (e) options or other securities issued under any equity
compensation plan maintained
by the Corporation for the benefit of employees of the Corporation, or (f) securities issued
as dividends payable-in-kind on preferred stock), the Corporation will offer to sell to each Other
Stockholder a portion of such securities equal to the percentage determined by dividing (i) the
number of shares of Corporation Securities (on a Fully Diluted Basis) (without duplication) then
held by each Other Stockholder by (ii) the number of shares of Common Stock outstanding (on a Fully
Diluted Basis). Other Stockholders will be entitled to purchase such stock or securities at the
same price and on the same terms as such stock or securities are to be offered to any other Person,
and shall agree to observe and comply with the same representations, warranties, covenants and
other terms and provisions to which such other Persons are subject, all as described in the written
notice provided by the Corporation pursuant to this Section 7.01 (it being understood that the
Other Stockholders shall execute and deliver such documents as the Corporation may reasonably
require to evidence such agreement). Each Other Stockholder must exercise its purchase rights
within twenty (20) days after receipt

19

 

of written notice from the Corporation describing in
reasonable detail the stock or securities being so offered, the purchase price thereof, the payment
terms and such Other Stockholder’s percentage allotment (or, if shorter, the period during which
other Persons to whom the shares or other securities will be issued are permitted to elect whether
or not to acquire such shares or other securities). Upon the expiration of such period, the
Corporation will be free to sell such stock or securities that such Other Stockholders have not
elected to purchase during the one hundred eighty (180) days following such expiration on terms and
conditions no more favorable to purchasers thereof than those offered to the Other Stockholders.
Any stock or securities offered or sold by the Corporation after such 180 day period (or the
portion thereof specified above) must be reoffered to each Other Stockholder pursuant to the terms
of this Section 7.01.

     Section 7.02. Convenience Sale. For convenience of administration, the Corporation may
offer and sell to third parties the shares of capital stock or other securities subject to the
purchase rights under Section 7.01 without first offering such shares or other securities to the
Other Stockholders, so long as the Other Stockholders are given the opportunity to purchase their
proportionate percentages of such shares or other securities within forty-five (45) days after the
close of such sale.

     Section 7.03. Termination. The provisions of Section 7.01 shall terminate upon the
consummation of a Partial Termination.

ARTICLE 8

Registration Rights

     Section 8.01. Piggyback Registration. (a) Whenever the Corporation proposes to register any
of its securities for an underwritten offering under the Securities Act, if the registration
statement proposed to be used by the
Corporation is not a registration statement on Form S-4 or S-8 (or any substitute form for
comparable purposes that may be adopted by the Commission) or a registration statement filed in
connection with an exchange offer or an offering of securities solely to the Corporation’s existing
security holders and the registration form to be used may be used for the registration of
Registrable Securities (a (“Piggyback Registration”) the Corporation will give prompt
written notice to all Stockholders holding Registrable Securities with respect of the proposed
offering at least thirty (30) days before the initial filing with the Commission of such
registration statement, and offer to include in such filing such Registrable Securities as any such
holder may request. Each such holder of Registrable Securities desiring to have Registrable
Securities registered under this Section 8.01 shall advise the Corporation in writing within
fifteen (15) days after the date of receipt of such notice from the Corporation, setting forth the
amount of such

20

 

Registrable Securities for which registration is requested. Subject to Section
8.01(c), the Corporation shall thereupon include in such filing the number of Registrable
Securities for which registration is so requested, and shall use its reasonable best efforts to
effect registration under the Securities Act of such Registrable Securities.

     (b) The Registration Expenses of the holders of Registrable Securities will be paid by the
Corporation in all Piggyback Registrations to the extent provided in 8.05.

     (c) If a Piggyback Registration is an underwritten registration on behalf of the Corporation
and the managing underwriters advise the Corporation in writing that in their opinion the number of
securities requested to be included in such registration exceeds the number that can be sold in an
orderly manner in such offering within a price range acceptable to the Corporation, will include in
such registration: (A) first, the securities the Corporation proposes to sell, (B) second, the
Registrable Securities and any other securities requested to be included in such registration by
ACAS and (C) third, the Registrable Securities and any other securities requested to be included in
such registration by holders other than ACAS, pro rata among such holders on the basis of the
number of shares owned by each such holder.

     (d) If the managing underwriters in either an underwritten primary or secondary registration
advise the Corporation in writing that in their opinion the relationship to the Corporation
(i.e., as officers, directors or stockholders) of the selling stockholders holding
Registrable Securities requested to be included in the registration statement will adversely effect
an orderly sale of Corporation Securities within a price range acceptable to the Corporation or the
holders initially requesting such registration, the Corporation may exclude from such registration
such amount up to all of such Registrable Securities of such selling stockholders as the managing
underwriters determine are desirable to complete such an orderly sale.

     Section 8.02. Demand Registration. In addition to the registration rights provided in
Section 8.01 above, if at any time the Corporation is eligible to use Commission Form S-3 (or any
successor form) for registration of secondary sales of Registrable Securities, any single
Stockholder of Registrable Securities holding two percent (2%) or more of the Common Stock, on a
Fully Diluted Basis, may request in writing that the Corporation register shares of Registrable
Securities on such form or any successor form. Upon receipt of such request, the Corporation will
promptly notify all such holders of Registrable Securities in writing of the receipt of such
request and each such holder may elect (by written notice sent to the Corporation within thirty
(30) days of receipt of the Corporation’s notice) to have its Registrable Securities included in
such registration pursuant to this

21

 

Section 8.02. Thereupon, the Corporation will, as soon as
practicable, use its best efforts to effect the registration on Form S-3 of all Registrable
Securities that the Corporation has so been requested to register by such holders for sale. The
Corporation will use its best efforts to maintain the effectiveness of any such registration
statement and to qualify and maintain its qualification for eligibility to use Form S-3 for such
purposes. The Corporation shall not be required to effect more than two (2) registrations pursuant
to this Section 8.02.

     Section 8.03. Lock-Up. (a) Each holder of Registrable Securities agrees not to effect any
Public Sale or distribution (including sales pursuant to Rule 144) of equity securities of the
Corporation, or any securities convertible into or exchangeable or exercisable for such securities,
during the thirty (30) days prior to and the 90 day period (or such longer period, not to exceed 90
additional days, as the managing underwriter shall require) beginning on the effective date of the
registration statement relating to any underwritten Piggyback Registration in which Registrable
Securities are included (except as part of such underwritten registration), unless the underwriters
managing the registered public offering otherwise agree.

     (b) The Corporation agrees (i) not to effect any Public Sale or distribution of its equity
securities, or any securities convertible into or exchangeable or exercisable for such securities,
during the seven (7) days prior to and during the sixty (60) day period beginning on the effective
date of any underwritten Piggyback Registration (except as part of such underwritten registration
or pursuant to registrations on Form S-8 or any successor form), unless the underwriters managing
the registered public offering otherwise agree, and (ii) to use its commercially reasonable efforts
to cause each holder of at least ten percent (10%) (on a Fully Diluted Basis) of its equity
securities, or any securities convertible into or exchangeable or exercisable for its equity
securities, purchased from the Corporation at any time after the date of this Agreement (other than
in a registered public offering) to agree not to effect any public sale or distribution (including
sales pursuant to Rule 144) of any such securities during such period (except as part of such
underwritten registration, if otherwise permitted), unless the underwriters managing the registered
public offering otherwise agree.

     Section 8.04. Registration Procedures. Whenever the holders of Registrable Securities have
requested that any Registrable Securities be registered as permitted by and pursuant to this
Agreement, the Corporation will use reasonable efforts to effect the registration and the sale of
such Registrable Securities in accordance with the intended method of disposition thereof, and
pursuant thereto the Corporation will use its reasonable best efforts to:

22

 

     (a) prepare and file with the Commission a registration statement with respect to such
Registrable Securities and use reasonable efforts to cause such registration statement to become
effective;

     (b) furnish to each seller of Registrable Securities such number of copies of such
registration statement, each amendment and supplement thereto, the prospectus included in such
registration statement (including each preliminary prospectus) and such other documents as such
seller may reasonably request in order to facilitate the disposition of the Registrable Securities
owned by such seller;

     (c) use reasonable efforts to register or qualify such Registrable Securities under such other
securities or blue sky laws of such jurisdictions as any seller of Registrable Securities
reasonably requests and do any and all other acts and things which may be reasonably necessary or
advisable to enable such seller to consummate the disposition in such jurisdictions of the
Registrable Securities owned by such seller (provided that the Corporation will not be required to
(i) qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify but for this subparagraph, (ii) subject itself to taxation in any such jurisdictions,
(iii) consent to general service of process in each such jurisdiction or (iv) undertake such
actions in any jurisdiction other than the states of the United States of America and the District
of Columbia);

     (d) notify each seller of such Registrable Securities, at any time when a prospectus relating
thereto is required to be delivered under the Securities Act, of the happening of any event as a
result of which the prospectus included in such registration statement contains an untrue statement
of a material fact or omits any fact necessary to make the statements therein not misleading, and,
at the request of any such seller, the Corporation will prepare a supplement or amendment to such
prospectus so that, as thereafter delivered to purchasers of such Registrable Securities, such
prospectus will not contain an untrue statement of a material fact or omit to state any fact
necessary to make the statements therein not misleading; provided, however, that each seller shall,
immediately upon receipt of any notice from the Corporation of the happening of any event of the
kind described in this paragraph (d), forthwith discontinue disposition of Registrable Securities
pursuant to the registration statement covering such Registrable Securities until the seller has
received copies of the supplement or amendment prepared in accordance with this paragraph (d) and,
if so directed by the Corporation, each seller shall deliver to the Corporation all copies, other
than permanent file copies then in the seller’s
possession, of the prospectus covering such Registrable Securities current at the time of
receipt of such notice;

     (e) use its reasonable best efforts to cause all such Registrable Securities to be listed on
each securities exchange on which similar securities

23

 

issued by the Corporation are then listed and,
if not so listed, to be quoted on the Nasdaq Stock Market and, if quoted on the Nasdaq Stock
Market, use its best efforts to secure designation of all such Registrable Securities covered by
such registration statements as a Nasdaq Stock Market “national market system security” within the
meaning of Rule 11Aa2-1 of the Commission;

     (f) provide a transfer agent and registrar for all such Registrable Securities not later than
the effective date of such registration statement;

     (g) enter into such customary agreements (including underwriting agreements in customary form)
and take all such other actions as the holders of a majority of the Registrable Securities being
sold or the underwriters, if any, reasonably request in order to expedite or facilitate the
disposition of such Registrable Securities (including, without limitation, effecting a stock split
or a combination of shares);

     (h) make available for inspection by any seller of Registrable Securities, any underwriter
participating in any disposition pursuant to such registration statement and any attorney,
accountant or other agent retained by any such seller or underwriter, all financial and other
records, pertinent corporate documents and properties of the Corporation, and cause the
Corporation’s officers, directors, employees and independent accountants to supply all information
reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection
with such registration statement;

     (i) otherwise use its reasonable best efforts to comply with all applicable rules and
regulations of the Commission, and make available to its security holders, as soon as reasonably
practicable, an earnings statement covering the period of at least twelve months beginning with the
first day of the Corporation’s first full calendar quarter after the effective date of the
registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of
the Securities Act (which may be achieved by, among other things, compliance with the conditions of
Rule 158 thereunder);

     (j) permit any holder of Registrable Securities which holder, in its judgment, might be deemed
to be an underwriter or a controlling person of the Corporation, to participate in the preparation
of such registration or comparable statement and to require the insertion therein of material,
furnished to the Corporation in writing, which in the reasonable judgment of such holder and its
counsel should be included; and

     (k) in the event of the issuance of any stop order suspending the effectiveness of a
registration statement, or of any order suspending or preventing the use of any related prospectus
or suspending the qualification of any Common Stock included in such registration statement for
sale in any jurisdiction, the

24

 

Corporation will use its reasonable best efforts promptly to obtain
the withdrawal of such order. If any such registration or comparable statement refers to any holder
by name or otherwise as the holder of any securities of the Corporation and if in its sole and
exclusive judgment such holder is or might be deemed to be a controlling person of the Corporation,
such holder shall have the right to require (i) to the extent permitted by law, the insertion
therein of language, in form and substance satisfactory to such holder and presented to the
Corporation in writing, to the effect that the holding by such holder of such securities is not to
be construed as a recommendation by such holder of the investment quality of the Corporation’s
securities covered thereby and that such holding does not imply that such holder will assist in
meeting any future financial requirements of the Corporation, (ii) in the event that such reference
to such holder by name or otherwise is not required by the Securities Act or any similar federal
statute then in force, the deletion of the reference to such holder; provided that such holder
shall furnish to the Corporation an opinion of counsel to such effect, which opinion and counsel
shall be reasonably satisfactory to the Corporation.

     Section 8.05. Expenses. All expenses incident to the Corporation’s performance of or
compliance with this Article 8, including without limitation all registration and filing fees, fees
and expenses of compliance with securities or blue sky laws, printing expenses, messenger and
delivery expenses, and fees and disbursements of counsel for the Corporation and all independent
certified public accountants and other Persons retained by the Corporation (all such expenses,
excluding underwriting discounts and commissions, being herein called will be borne by the
Corporation. All fees for separate counsel and for seller underwriting discounts and commissions
will be borne by the sellers of the securities sold pursuant to the registration.

     Section 8.06. Indemnification. (a) The Corporation agrees to indemnify, to the extent
permitted by law, each holder of Registrable Securities, its officers and directors and each Person
who controls such holder (within the meaning of the Securities Act) against all losses, claims,
damages, liabilities and expenses caused by any untrue or alleged untrue statement of material fact
contained in any registration statement, prospectus or preliminary prospectus or any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein not misleading or other violation by the
Corporation of the Securities Act of 1933 or other laws relating to such registration, except
insofar as the same are caused by or contained in any information furnished in writing to the
Corporation by such holder expressly for use therein or by such holder’s failure to deliver a copy
of the registration statement or prospectus or any amendments or supplements thereto after the
Corporation has furnished such holder with a sufficient number of copies
of the same. In connection with an underwritten offering, the Corporation will indemnify such
underwriters, their officers and directors and each Person who

25

 

controls such underwriters (within
the meaning of the Securities Act) to the same extent as provided above with respect to the
indemnification of the holders of Registrable Securities.

     (b) In connection with any registration statement in which a holder of Registrable Securities
is participating pursuant to the provisions of this Agreement, each such holder will furnish to the
Corporation in writing such information and affidavits as the Corporation reasonably requests for
use in connection with any such registration statement or prospectus and will indemnify the
Corporation, its directors and officers and each Person who controls the Corporation (within the
meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses
resulting from any untrue or alleged untrue statement of material fact contained in the
registration statement, prospectus or preliminary prospectus or any amendment thereof or supplement
thereto or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein not misleading but only to the extent that such untrue
statement or omission is contained in any information or affidavit so furnished in writing by such
holder, provided that in no event will the indemnity provided for in this Section 8.06(b) exceed
the net proceeds from the offering received by the indemnifying holder.

     (c) Any Person entitled to indemnification hereunder will (i) give prompt written notice to
the indemnifying party of any claim with respect to which it seeks indemnification and (ii) unless
in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and
indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume
the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such
defense is assumed, the indemnifying party will not be subject to any liability for any settlement
made by the indemnified party without its consent (but such consent will not be unreasonably
withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a
claim will not be obligated to pay the fees and expenses of more than one counsel for all parties
indemnified by such indemnifying party with respect to such claim, unless in the reasonable
judgment of any indemnified party a conflict of interest may exist between such indemnified party
and any other of such indemnified parties with respect to such claim.

     (d) The indemnification provided for under this Agreement will remain in full force and effect
regardless of any investigation made by or on behalf of the indemnified party or any officer,
director or controlling Person of such indemnified party and will survive the transfer of
securities. The Corporation also agrees to make such provisions, as are reasonably requested by any
indemnified

26

 

party, for contribution to such party in the event the Corporation’s indemnification is
unavailable for any reason.

     Section 8.07. Requirements for Underwritten Offerings. No Person may participate in any
registration hereunder that is underwritten unless such Person (a) agrees to sell such Person’s
securities on the basis provided in any underwriting arrangements approved by the Person or Persons
entitled hereunder to approve such arrangements and (b) completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents required under the
terms of such underwriting arrangements; provided that no holder of Registrable Securities included
in any underwritten registration shall be required to make any representations or warranties to the
Corporation or the underwriters other than representations and warranties regarding such holder and
such holder’s intended method of distribution.

ARTICLE 9

Equitable Remedies

     Section 9.01. The Corporation Securities are agreed to be unique, and recognizing that the
remedy at law for any breach or threatened breach by a party hereto of the covenants and conditions
set forth herein would be inadequate, and further recognizing that any such breach or threatened
breach would cause immediate, irreparable and permanent damage to the parties, the extent of which
would be impossible or difficult to ascertain, the parties hereto agree that in the event of any
such breach or threatened breach, and in addition to any and all remedies at law or otherwise
provided herein, any party hereto may specifically enforce the terms of this Agreement and may
obtain temporary and/or permanent injunctive relief (including a mandatory injunction) without the
necessity of proving actual damage or the lack of an adequate remedy at law, and, to the extent
permissible under applicable rules of provision and statutes, a temporary injunction may be granted
immediately upon the commencement of any suit hereunder regardless of whether the breaching party
or parties have actually received notice thereof. Such remedy shall be cumulative and not
exclusive, and shall be in addition to any other remedy or remedies available to the parties.

ARTICLE 10

Board Of Directors

     Section 10.01. Board of Directors Composition. Subject to the terms of any agreement or
document governing any Debt Instrument, including, without limitation, Section 7.1(i) of the
Purchase Agreement, the Corporation’s Board of Directors shall consist of a maximum of five (5)
directors and shall initially

27

 

consist of the following three (3) directors: Robert Klein, who shall
initially be non-executive Chairman, Donald Hartman and Thomas D. Logan.

     Section 10.02. Agreement to Vote. Each of the Stockholders agrees to vote its shares of
voting Common Stock (and the Corporation agrees to vote, and to cause each Subsidiary to vote,
shares of voting stock in its direct subsidiaries) in any election of directors in a manner
consistent with Section 10.01 and, in furtherance thereof, in accordance with the terms of any
agreement or document governing any Debt Instrument including, without limitation, Section 7.1(i)
of the Purchase Agreement.

     Section 10.03. Confidentiality Duties. Notwithstanding the fiduciary duties of directors
regarding the Corporation’s confidential information under the Delaware General Corporation Law,
each of the directors of the Corporation who are employed by ACAS shall be and is hereby authorized
to disclose to ACAS confidential information of the Corporation to the extent such disclosure is in
furtherance of such entity’s administration of its investment in the Corporation in the ordinary
course of its business.

ARTICLE 11

Enabling Provision

     Section 11.01. The provisions of this Agreement shall be binding upon all holders of
Corporation Securities issued subsequent hereto and shall be binding upon all subsequent holders of
Corporation Securities whether now or hereafter issued and outstanding. The Corporation shall, upon
further issuance or Transfer of any Corporation Securities (including as a result of the exercise
of any option agreements), require the holder(s) of such newly issued or Transferred Corporation
Securities to enter into a counterpart copy of this Agreement, and shall include the restrictive
legends set forth in Article 4 upon any such newly issued or Transferred Corporation Securities,
and such new holder(s) shall be deemed “Stockholders” (and, as appropriate, “Other Stockholders”
and “Employee Stockholders”) for all purposes of this Agreement. For such purposes, any transferee
from ACAS of Corporation Securities shall be considered to have the same rights and obligations
hereunder as did ACAS with regard to such Corporation Securities.

ARTICLE 12

Termination of Agreement

     Section 12.01. Events of Termination. This Agreement shall automatically terminate upon the
happening of any of the following events: (a) the

28

 

affirmative vote of ACAS plus the affirmative
vote of the holders of not less than fifty-one percent (51%) of the Common Stock subject to this
Agreement, other than Common Stock owned by ACAS or (b) the registration under the Securities Act
of not less than fifty percent (50%) of the then outstanding Common Stock, provided that Article 8
and Article 10 shall survive any termination pursuant to
clause (b) hereof where less than 50% of the shares of Common Stock then outstanding are
registered.

     Section 12.02. Transfer of All Securities. Upon the permitted Transfer by any Stockholder,
executor or other entity of all Corporation Securities owned or held by him, her or it and, upon
payment of any consideration to which such Stockholder is entitled, such Stockholder shall have no
further rights or privileges under this Agreement or otherwise be entitled to the benefits hereof.
However, such Transfer shall not relieve a Stockholder, his or her executor or his, her or its
successors or assigns from liability hereunder in the event of a breach by any such Stockholder of
his, her or its duties hereunder prior to such Transfer.

ARTICLE 13

Miscellaneous Provisions

     Section 13.01. Counterparts. This Agreement may be executed in two or more counterparts,
each of which shall serve as an original of the party executing the same, but all of which shall
constitute but one and the same Agreement.

     Section 13.02. Binding Agreement. This Agreement shall be binding upon the parties hereto,
their heirs, administrators, executors, successors and assigns, and the parties hereto do covenant
and agree that they themselves and their heirs, executors, administrators, successors and assigns
will execute any and all instruments, releases assignments, and consents that may be required of
them in accordance with the provisions of this Agreement.

     Section 13.03. Headings. All headings set forth in this Agreement are intended for
convenience only and shall not control or affect the meaning, construction or effect of this
Agreement or of any of the provisions hereof.

     Section 13.04. Singular and Plural. As used herein, the singular shall include the plural,
the plural refer to the singular and any use of the male or female gender shall include the other
gender, all wherever the same shall be applicable and when the context shall admit or require.

     Section 13.05. Enforceability. The invalidity or enforceability of any particular provision
of this Agreement shall not affect the enforceability of or invalidate the other provisions hereof,
and this Agreement shall be construed in

29

 

all respects as if such invalid or unenforceable
provisions had never been part hereof and were omitted herefrom.

     Section 13.06. Waivers. Any waiver, permission, consent or approval of any kind or nature
by any party hereto, of any breach or default under this Agreement, or any waiver of any provision
of this Agreement by any party hereto, must be in writing and shall be effective only in the
specific instance and for the
specific purpose given, and shall be effective only to the extent in such writing specifically
set forth, and the same shall not operate or be construed as a waiver of any subsequent breach,
default, provision or condition of this Agreement by any party hereto, including the party to whom
originally given.

     Section 13.07. Amendments. Other than as provided in Section 12.01, this Agreement may only
be amended, modified or revoked in whole or in part by a writing signed by (a) ACAS, (b) the
holders of not less than fifty-one percent (51%) of the Common Stock subject to this Agreement,
other than Common Stock owned by ACAS and (c) the Corporation. This Agreement contains the entire
understanding of the parties hereto with respect to the subject matter hereof and supersedes any
and all other agreements, whether oral or written, relating to such subject matter, by and between
the parties hereto.

     Section 13.08. Notices. Any notice required or permitted hereunder shall be given in
writing, addressed to the notice recipient at the address shown in the stock records of the
Corporation. If the Corporation is the notice recipient, the notice shall be sent to the
Corporation’s Secretary at the Corporation’s headquarters address, with a copy to (a) American
Capital Strategies, Ltd., Two Bethesda Metro Center, 14th Floor, Bethesda, MD 20814, Attention:
Compliance Officer, (b) American Capital Strategies, Ltd., 461 Fifth Avenue, 25th Floor, New York,
NY, 10153, Attention: Robert Klein, Managing Director and Todd Wilson, Vice President and (c) Weil,
Gotshal and Manges LLP, 767 Fifth Avenue, New York, NY 10153, Attention: Christopher K. Aidun, Esq.
The notice shall be sent by United States Mail, first class postage prepaid, return receipt
requested, by Federal Express or other nationally recognized overnight parcel delivery service for
next day delivery; or by hand delivery with a receipt confirmation requested. Notice given in
accordance with this paragraph shall be presumed to have been delivered and received three (3) days
after mailing if sent by United States Mail, first class, one day after mailing if sent for next
day deliver by FedEx or equivalent; and on the day of delivery if hand delivered. Notice may also
be given by telecopy, but such notice will not be effective unless the notice provider obtains a
confirmation of receipt of the telecopy signed by the notice recipient.

     Section 13.09. Renewals. Reference to this Agreement herein shall include any amendment or
renewal hereof.

30

 

     Section 13.10. Governing Law. This Agreement shall be deemed to be a contract governed by
the laws of the State of Delaware and shall for all purposes be construed in accordance with the
laws of such state, without reference to the conflicts of laws provisions thereof.

     Section 13.11. Effectiveness. This Agreement shall be and become effective in general as of
the date of execution hereof by the Corporation and ACAS. It shall be effective as to each
subsequent signatory upon its signature hereto.

* * *

31

 

     IN WITNESS WHEREOF, the parties have caused this Stockholders Agreement to be executed, by
their duly authorized officers or agents where applicable, as of the same day and year first above
written.

	 	 	 	 	 
	 	IST ACQUISITIONS, INC.

 	 
	 	By:  	/s/ Robert Klein
 	 
	 	 	Name:  	Robert Klein 	 
	 	 	Title:  	Authorized Signatory 	 
	 

	 	 	 	 	 
	 	AMERICAN CAPITAL STRATEGIES, LTD.

 	 
	 	By:  	/s/ Robert Klein
 	 
	 	 	Name:  	Robert Klein 	 
	 	 	Title:  	Authorized Signatory 	 
	 

SIGNATURE PAGE TO IST ACQUISITIONS, INC.

STOCKHOLDERS AGREEMENT

32

 

EXHIBIT A

COMPETITIVE ACTS

     1. Confidentiality. Employee Stockholder shall not, during the term of Employee
Stockholder’s employment with the Corporation or at any time thereafter, directly or indirectly,
divulge, use, furnish, disclose, exploit or make available to any person or entity, whether or not
a competitor of the Corporation, any Unauthorized disclosure of Confidential Information. All
references herein to “the Corporation” shall be deemed to include its Subsidiaries.

     As used herein, the term:

     (a) “Confidential Information” shall mean trade secrets, confidential or
proprietary information, and all other information, documents or materials, relating to,
owned, developed or possessed by the Corporation, whether in tangible or intangible form.
Confidential Information includes, but is not limited to, (i) financial information, (ii)
products, (iii) product and service costs, prices, profits and sales, (iv) new business,
technical or other ideas, proposals, plans and designs, (v) business strategies, (vi)
product and service plans, (vii) marketing plans and studies, (viii) forecasts, (ix)
budgets, (x) projections, (xi) computer programs, (xii) data bases and the documentation
(and information contained therein), (xiii) computer access codes and similar information,
(xiv) source code, (xv) know-how, technologies, concepts and designs, including, without
limitation, patent applications, (xvi) research projects and all information connected
with research and development efforts, (xvii) records, (xviii) business relationships,
methods and recommendations, (xix) existing or prospective client, customer, vendor and
supplier information (including, but not limited to, identities, needs, transaction
histories, volumes, characteristics, agreements, prices, identities of individual
contacts, and spending, preferences or habits), (xx) training manuals and similar
materials used by the Corporation in conducting its business operations, (xxi) skills,
responsibilities, compensation and personnel files of Corporation employees, directors and
independent contractors, (xxii) competitive analysis, (xxiii) contracts with other
parties, and (xxiv) other confidential or proprietary information that has not been made
available to the general public by the senior management of the Corporation. Confidential
Information shall not include information that (I) is or becomes generally available to
the public through no act or omission on the part of Employee Stockholder, (II) is
hereafter received on a non-confidential basis by Employee Stockholder from a third party
who has the lawful right to disclose such information, or (III) Employee Stockholder is
required to disclose pursuant to court order or law.

33

 

     (b) “Unauthorized” shall mean: (i) in contravention of the policies or
procedures of the Corporation; (ii) otherwise inconsistent with any measures taken by the
Corporation to protect its interests in the Confidential Information; (iii) in
contravention of any lawful instruction or directive, either written or oral, of a
director, officer or employee of the Corporation empowered to issue such instruction or
directive; (iv) in contravention of any duty existing under law or contract; or (v) to the
detriment of the Corporation.

     Employee
Stockholder further agrees to take all reasonable measures to prevent
unauthorized persons or entities from obtaining or using Confidential
Information. Promptly upon termination, for any reason, of Employee
Stockholder’s employment with the Corporation, Employee Stockholder
agrees to deliver to the Corporation all property and materials
within Employee Stockholder’s possession or control which belong to
the Corporation or which contain Confidential Information.

     2. Non-Competition; Non-Solicitation.

     (a) During the term of Employee Stockholder’s employment with the Corporation and for
a term of three (3) years commencing as of the date of termination of Employee
Stockholder’s employment with the Corporation (the “Non-Compete Period”), whenever
the same shall occur and for whatever reason, Employee Stockholder will not, directly or
indirectly:

     (i) own any interest in, manage, control, participate in, engage in,
consult with, or render services for, whether as an individual, officer,
director, proprietor, employee, partner, member, investor (other than solely as
a holder of less than two percent (2%) of the outstanding capital stock of a
corporation whose shares are publicly traded on a national securities exchange
or through a national market system), creditor, consultant, advisor, sales
representative, agent or other participant in, the business of ownership,
operation or management or franchising (whether as a franchisor, franchisee or
otherwise) of any Person engaged in any business the Corporation or any
Subsidiary engaged in during the twenty four (24) month period prior to
termination of such Employee Stockholder’s employment anywhere in the world (the
“Restricted Business”); or

     (ii) make any statements or perform any acts intended to advance the
interest of any person or entity engaged in or proposing to engage in a
Restricted Business in any way that could injure the interests of the
Corporation or any Subsidiary.

     (b) During the Non-Compete Period, Employee Stockholder will not, directly or
indirectly, (i) induce or attempt to induce any officer or employee of the Corporation or
any Subsidiary to leave the employ of the Corporation or such Subsidiary, or in any way
interfere with the relationship between the Corporation or any Subsidiary and any officer
or employee thereof, (ii) hire any person who is, or was, an employee of the

34

 

Corporation
or any Subsidiary within six months prior to the hiring or offer to hire or (iii) induce
or attempt to induce any customer, supplier,
licensee, licensor, franchisee or other business relation of the Corporation or any
Subsidiary to cease doing business with the Corporation or such Subsidiary, or in any way
interfere with the relationship between any such customer, supplier, licensee, licensor,
franchise or business relation and the Corporation or any Subsidiary (including, without
limitation, making any negative statements or communications about the Corporation, any
Subsidiary or any Affiliate of the Corporation).

35

 

SCHEDULE A

Stockholders

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	Shares of	 	Shares of	 	 
	 	 	 	 	 	 	 	 	 	 	Common	 	Common	 	 
	 	 	Shares of	 	Shares of	 	Stock Upon	 	Stock Upon	 	Employee
	 	 	Common	 	Preferred	 	Exercise of	 	Exercise of	 	Stockholder
	Name	 	Stock	 	Stock	 	Warrants	 	Options	 	Yes/No
	American Capital Strategies, Ltd.
	 	 	10,000	 	 	 	22,000	 	 	 	83,458	 	 	 	N/A	 	 	No

36

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}]]